Last reviewed · How we verify
Eyecyte-RPE™
At a glance
| Generic name | Eyecyte-RPE™ |
|---|---|
| Also known as | Subretinal Injection, Oral Tacrolimus, Oral Mycophenolate Sodium |
| Sponsor | Eyestem Research Pvt. Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |